Paris-based @WhitelabG, a #BioTech company that uses #AI to design the building blocks of #genomic medicines, has closed a €23.2 million Series B #funding round... | TOKERO

Paris-based @WhitelabG, a #BioTech company that uses #AI to design the building blocks of #genomic medicines, has closed a €23.2 million Series B #funding round. 🇫🇷 🧬 🤖

https://t.co/GhkgGFLPHO https://t.co/5XMIfVpcL3

3